Bioleaders

BioLeaders Corporation is a research-based, clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. Founded in 1999, the company develops innovative immunotherapies and vaccines utilizing proprietary drug delivery technologies to treat cancer, infectious diseases, and rare diseases by inducing the body's innate and adaptive immunity systems. BioLeaders has four primary therapeutic focus areas: Human papillomavirus (HPV)-related diseases, anti-virals for infectious diseases, immunostimulatory therapeutics for cancer and dermatology, and immunotherapy vaccines spanning oncology, cardiovascular, CNS, and muscle-wasting diseases. The company's orally-delivered prescription prophylactic and therapeutic applications represent a differentiated approach to vaccine administration. BioLeaders is a publicly listed company in South Korea and maintains a pipeline of proprietary drug candidates targeting unmet medical needs across multiple disease indications.